Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T14:11:26.497Z.
Calculation as of: 2026-10-06T14:11:26.497Z.
Quote observation: 2026-10-06T14:10:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8c517f571e23d8c9640577b72a0d01a1674ca2fb527f0620093024032568825b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$5.13B
EBITDA Yield
6.13%
TTM Avg
6.37%
3Y Avg
5.19%
5Y Avg
4.76%
Market Cap
$5.11B
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.86B
EBITDA Yield
N/A
TTM Avg
0.05%
3Y Avg
0.05%
5Y Avg
0.05%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | $5.16B | N/A | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.13B | 6.13% | 6.37% | 5.19% | 4.76% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.11B | N/A | N/A | N/A | N/A |
| CRISPR Therapeutics AG (CRSP)vs › | $5.29B | N/A | 8.18% | 5.23% | 5.23% |
| Erasca, Inc. (ERAS)vs › | $4.93B | N/A | N/A | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.36B | 4.15% | 4.42% | 3.12% | 2.52% |
| BillionToOne, Inc. (BLLN)vs › | $4.91B | 1.23% | 0.79% | 0.79% | 0.79% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.86B | N/A | 0.05% | 0.05% | 0.05% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.71B | N/A | N/A | N/A | N/A |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.57B | 3.23% | 3.04% | 3.04% | 3.04% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
